MAGNORA ASA(OSL:MGN) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, MGN scores 5 out of 10 in our fundamental rating. MGN was compared to 19 industry peers in the Independent Power and Renewable Electricity Producers industry. While MGN has a great health rating, its profitability is only average at the moment. MGN is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MGN had positive earnings in the past year.

MGN had a negative operating cash flow in the past year.

MGN had positive earnings in 4 of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: MGN reported negative operating cash flow in multiple years.

1.2 Ratios

MGN has a better Return On Assets (100.82%) than 100.00% of its industry peers.

MGN has a better Return On Equity (137.85%) than 100.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	100.82%
ROE	137.85%
ROIC	N/A

ROA(3y)45.75%

ROA(5y)25.52%

ROE(3y)62.41%

ROE(5y)34.96%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MGN has a Profit Margin of 25808.70%. This is amongst the best in the industry. MGN outperforms 100.00% of its industry peers.

MGN's Profit Margin has improved in the last couple of years.

MGN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	25808.7%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y250.83%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MGN does not have a ROIC to compare to the WACC, probably because it is not profitable.

MGN has less shares outstanding than it did 1 year ago.

MGN has more shares outstanding than it did 5 years ago.

The debt/assets ratio for MGN is higher compared to a year ago.

2.2 Solvency

MGN has an Altman-Z score of 5.97. This indicates that MGN is financially healthy and has little risk of bankruptcy at the moment.

MGN has a better Altman-Z score (5.97) than 100.00% of its industry peers.

There is no outstanding debt for MGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	5.97

ROIC/WACCN/A

WACC8.54%

2.3 Liquidity

MGN has a Current Ratio of 1.94. This is a normal value and indicates that MGN is financially healthy and should not expect problems in meeting its short term obligations.

MGN's Current ratio of 1.94 is amongst the best of the industry. MGN outperforms 84.21% of its industry peers.

MGN has a Quick Ratio of 1.94. This is a normal value and indicates that MGN is financially healthy and should not expect problems in meeting its short term obligations.

MGN has a Quick ratio of 1.94. This is amongst the best in the industry. MGN outperforms 84.21% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.94
Quick Ratio	1.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 210.84%, which is quite impressive.

The Earnings Per Share has been growing by 87.45% on average over the past years. This is a very strong growth

MGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -80.99%.

MGN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -43.96% yearly.

EPS 1Y (TTM)210.84%

EPS 3YN/A

EPS 5Y87.45%

EPS Q2Q%6241%

Revenue 1Y (TTM)-80.99%

Revenue growth 3Y-46.71%

Revenue growth 5Y-43.96%

Sales Q2Q%226.97%

3.2 Future

Based on estimates for the next years, MGN will show a decrease in Earnings Per Share. The EPS will decrease by -3.93% on average per year.

The Revenue is expected to decrease by -0.81% on average over the next years.

EPS Next Y-21.58%

EPS Next 2Y28.37%

EPS Next 3Y-3.93%

EPS Next 5YN/A

Revenue Next Year-8.07%

Revenue Next 2Y1.5%

Revenue Next 3Y-0.81%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MGN is valuated cheaply with a Price/Earnings ratio of 5.50.

MGN's Price/Earnings ratio is rather cheap when compared to the industry. MGN is cheaper than 94.74% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 25.82, MGN is valued rather cheaply.

The Price/Forward Earnings ratio is 3.34, which indicates a rather cheap valuation of MGN.

MGN's Price/Forward Earnings ratio is rather cheap when compared to the industry. MGN is cheaper than 100.00% of the companies in the same industry.

MGN is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	5.5
Fwd PE	3.34

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

MGN's earnings are expected to decrease with -3.93% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)0.06

EPS Next 2Y28.37%

EPS Next 3Y-3.93%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MGN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MAGNORA ASA

OSL:MGN (5/23/2025, 7:00:00 PM)

23.05

+0.2 (+0.88%)

Chartmill FA Rating

GICS SectorUtilities

GICS IndustryGroupUtilities

GICS IndustryIndependent Power and Renewable Electricity Producers

Earnings (Last)04-25 2025-04-25/bmo

Earnings (Next)07-18 2025-07-18

Inst Owners11.34%

Inst Owner ChangeN/A

Ins Owners5.78%

Ins Owner ChangeN/A

Market Cap1.52B

Analysts86.67

Price Target38.08 (65.21%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend4.62

Dividend Growth(5Y)0.46%

DP50.45%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)60.49%

Min Revenue beat(2)46.86%

Max Revenue beat(2)74.12%

Revenue beat(4)4

Avg Revenue beat(4)46.59%

Min Revenue beat(4)20.97%

Max Revenue beat(4)74.12%

Revenue beat(8)5

Avg Revenue beat(8)16.6%

Revenue beat(12)8

Avg Revenue beat(12)275.21%

Revenue beat(16)10

Avg Revenue beat(16)232.41%

PT rev (1m)-0.89%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)-96.39%

EPS NY rev (1m)0%

EPS NY rev (3m)13.94%

Revenue NQ rev (1m)15.46%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)25.13%

Revenue NY rev (3m)25.13%

Valuation

		Industry Rank	Sector Rank
PE	5.5
Fwd PE	3.34
P/S	659.23
P/FCF	N/A
P/OCF	N/A
P/B	3.52
P/tB	5.42
EV/EBITDA	N/A

EPS(TTM)4.19

EY18.18%

EPS(NY)6.9

Fwd EY29.93%

FCF(TTM)-1.49

FCFYN/A

OCF(TTM)-1.49

OCFYN/A

SpS0.03

BVpS6.55

TBVpS4.25

PEG (NY)N/A

PEG (5Y)0.06

Profitability

		Industry Rank	Sector Rank
ROA	100.82%
ROE	137.85%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	25808.7%
GM	N/A
FCFM	N/A

ROA(3y)45.75%

ROA(5y)25.52%

ROE(3y)62.41%

ROE(5y)34.96%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y250.83%

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	9.09%
Cap/Sales	4.35%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.94
Quick Ratio	1.94
Altman-Z	5.97

F-Score4

WACC8.54%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)19.76%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)210.84%

EPS 3YN/A

EPS 5Y87.45%

EPS Q2Q%6241%

EPS Next Y-21.58%

EPS Next 2Y28.37%

EPS Next 3Y-3.93%

EPS Next 5YN/A

Revenue 1Y (TTM)-80.99%

Revenue growth 3Y-46.71%

Revenue growth 5Y-43.96%

Sales Q2Q%226.97%

Revenue Next Year-8.07%

Revenue Next 2Y1.5%

Revenue Next 3Y-0.81%

Revenue Next 5YN/A

EBIT growth 1Y75.76%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-19.3%

EBIT Next 3Y-8.1%

EBIT Next 5YN/A

FCF growth 1Y-252.16%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-535.07%

OCF growth 3YN/A

OCF growth 5YN/A

MAGNORA ASA (MGN.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens